Clinical and demographic characteristics of study participants.

A total of 30 pregnant subjects were enrolled in this study and categorized into 6 different groups based on infection/vaccination status: i) Participants infected during the first trimester of gestation (Group 1T); ii) Participants infected during the second trimester (Group 2T); iii) Participants infected during the third trimester (Group 3T); iv) Participants testing positive for SARS-CoV-2 infection by PCR at the time of delivery (Delivery Group); v) Healthy participants without infection or vaccination (Control Group); vi) Participants fully mRNA-vaccinated by delivery (Vaccinated Group). In the “All” column, characteristics of all participants regardless of infection and vaccination status are summarized.